Literature DB >> 27531929

SiglecF+Gr1hi eosinophils are a distinct subpopulation within the lungs of allergen-challenged mice.

Caroline M Percopo1, Todd A Brenner1, Michelle Ma1, Laura S Kraemer1, Reem M A Hakeem2, James J Lee3, Helene F Rosenberg4.   

Abstract

Although eosinophils as a group are readily identified by their unique morphology and staining properties, flow cytometry provides an important means for identification of subgroups based on differential expression of distinct surface Ags. Here, we characterize an eosinophil subpopulation defined by high levels of expression of the neutrophil Ag Gr1 (CD45+CD11c-SiglecF+Gr1hi). SiglecF+Gr1hi eosinophils, distinct from the canonical SiglecF+Gr1- eosinophil population, were detected in allergen-challenged wild-type and granule protein-deficient (EPX-/- and MBP-1-/-) mice, but not in the eosinophil-deficient ΔdblGATA strain. In contrast to Gr1+ neutrophils, which express both cross-reacting Ags Ly6C and Ly6G, SiglecF+Gr1hi eosinophils from allergen-challenged lung tissue are uniquely Ly6G+ Although indistinguishable from the more-numerous SiglecF+Gr1- eosinophils under light microscopy, FACS-isolated populations revealed prominent differences in cytokine contents. The lymphocyte-targeting cytokines CXCL13 and IL-27 were identified only in the SiglecF+Gr1hi eosinophil population (at 3.9 and 4.8 pg/106 cells, respectively), as was the prominent proinflammatory mediator IL-13 (72 pg/106 cells). Interestingly, bone marrow-derived (SiglecF+), cultured eosinophils include a more substantial Gr1+ subpopulation (∼50%); Gr1+ bmEos includes primarily a single Ly6C+ and a smaller, double-positive (Ly6C+Ly6G+) population. Taken together, our findings characterize a distinct SiglecF+Gr1hi eosinophil subset in lungs of allergen-challenged, wild-type and granule protein-deficient mice. SiglecF+Gr1hi eosinophils from wild-type mice maintain a distinct subset of cytokines, including those active on B and T lymphocytes. These cytokines may facilitate eosinophil-mediated immunomodulatory responses in the allergen-challenged lung as well as in other distinct microenvironments. © Society for Leukocyte Biology.

Entities:  

Keywords:  allergy; cytokines; flow cytometry; inflammation

Mesh:

Substances:

Year:  2016        PMID: 27531929      PMCID: PMC5166438          DOI: 10.1189/jlb.3A0416-166R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  44 in total

1.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

2.  Phenotypic plasticity and targeting of Siglec-F(high) CD11c(low) eosinophils to the airway in a murine model of asthma.

Authors:  H Abdala Valencia; L F Loffredo; A V Misharin; S Berdnikovs
Journal:  Allergy       Date:  2015-10-20       Impact factor: 13.146

3.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

4.  Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis.

Authors:  Van Trung Chu; Alexander Beller; Sebastian Rausch; Julia Strandmark; Michael Zänker; Olga Arbach; Andrey Kruglov; Claudia Berek
Journal:  Immunity       Date:  2014-04-17       Impact factor: 31.745

Review 5.  Ly6 family proteins in neutrophil biology.

Authors:  Pui Y Lee; Jun-Xia Wang; Emilio Parisini; Christopher C Dascher; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2013-03-29       Impact factor: 4.962

Review 6.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".

Authors:  James J Lee; Elizabeth A Jacobsen; Sergei I Ochkur; Michael P McGarry; Rachel M Condjella; Alfred D Doyle; Huijun Luo; Katie R Zellner; Cheryl A Protheroe; Lian Willetts; William E Lesuer; Dana C Colbert; Richard A Helmers; Paige Lacy; Redwan Moqbel; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

Review 7.  Re-defining the unique roles for eosinophils in allergic respiratory inflammation.

Authors:  E A Jacobsen; N A Lee; J J Lee
Journal:  Clin Exp Allergy       Date:  2014-09       Impact factor: 5.018

8.  Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice.

Authors:  Jean M Daley; Alan A Thomay; Michael D Connolly; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2007-09-20       Impact factor: 4.962

9.  Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.

Authors:  Lisa A Spencer; Craig T Szela; Sandra A C Perez; Casey L Kirchhoffer; Josiane S Neves; Amy L Radke; Peter F Weller
Journal:  J Leukoc Biol       Date:  2008-10-07       Impact factor: 4.962

10.  IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.

Authors:  Kathleen R Bartemes; Koji Iijima; Takao Kobayashi; Gail M Kephart; Andrew N McKenzie; Hirohito Kita
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

View more
  33 in total

Review 1.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

2.  Cytokine Diversity in Human Peripheral Blood Eosinophils: Profound Variability of IL-16.

Authors:  Michelle Ma; Caroline M Percopo; Daniel E Sturdevant; Albert C Sek; Hirsh D Komarow; Helene F Rosenberg
Journal:  J Immunol       Date:  2019-06-10       Impact factor: 5.422

Review 3.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 4.  Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space.

Authors:  Anupama Ariyaratne; Constance A M Finney
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

5.  FACS isolation of live mouse eosinophils at high purity via a protocol that does not target Siglec F.

Authors:  Wendy E Geslewitz; Caroline M Percopo; Helene F Rosenberg
Journal:  J Immunol Methods       Date:  2017-12-16       Impact factor: 2.303

6.  Regulator of G protein signaling 5 restricts neutrophil chemotaxis and trafficking.

Authors:  Eunice C Chan; Chunguang Ren; Zhihui Xie; Joseph Jude; Tolga Barker; Cynthia A Koziol-White; Michelle Ma; Reynold A Panettieri; Dianqing Wu; Helene F Rosenberg; Kirk M Druey
Journal:  J Biol Chem       Date:  2018-06-21       Impact factor: 5.157

7.  Differential attenuation of β2 integrin-dependent and -independent neutrophil migration by Ly6G ligation.

Authors:  Pierre Cunin; Pui Y Lee; Edy Kim; Angela B Schmider; Nathalie Cloutier; Alexandre Pare; Matthias Gunzer; Roy J Soberman; Steve Lacroix; Eric Boilard; Craig T Lefort; Peter A Nigrovic
Journal:  Blood Adv       Date:  2019-02-12

8.  Eosinophils and eosinophil-associated diseases: An update.

Authors:  Jeremy A O'Sullivan; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2017-10-16       Impact factor: 10.793

9.  Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens.

Authors:  W E Geslewitz; C M Percopo; H F Rosenberg
Journal:  Clin Exp Allergy       Date:  2017-11-22       Impact factor: 5.018

10.  Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways.

Authors:  Caroline M Percopo; Julia O Krumholz; Elizabeth R Fischer; Laura S Kraemer; Michelle Ma; Karen Laky; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2018-10-04       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.